Sign Up Today and Learn More About MDimune Stock
Invest in or calculate the value of your shares in MDimune or other pre-IPO companies through EquityZen's platform.
MDimune Stock (MDIM)
MDimune is a therapeutics company for smart drug delivery platform.
About MDimune Stock
Industries
Software, Artificial Intelligence, Data and Analytics
MDimune Press Mentions
Stay in the know about the latest news on MDimune
Saundra Pelletier, Evofem Biosciences’ CEO, Dr. Friedrich Kapp, Co-CEO of Adimune, and Chris Mitton, President of Pearsanta, Will Join Aditxt Weekly Update on June 6
businesswire • Jun 05, 2025
Aditxt, Inc (ADTX) Subsidiary Adimune to Ship Drug Substances for Final Drug Product Formulation of ADI-100
streetinsider • Mar 06, 2025
Device for manufacturing cell-derived vesicles and manufacturing method using …
patents • Feb 15, 2025
Cell-derived vesicles with increased cellular uptake capacity and method for …
patents • Feb 15, 2025
Cell-derived vesicle rich in protein homeostasis regulators and method of …
patents • Feb 15, 2025
Join now and verify your accreditation status to gain access to:
- MDimune Current Valuation
- MDimune Stock Price
- MDimune Management
- Available deals in MDimune and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- MDimune Cap Table and Funding History by Share Class and Liquidity Preferences
- MDimune Revenue and Financials
- MDimune Highlights
- MDimune Business Model
- MDimune Risk Factors
- MDimune Research Report from SACRA Research
Trading MDimune Stock
How to invest in MDimune stock?
Accredited investors can buy pre-IPO stock in companies like MDimune through EquityZen funds. These investments are made available by existing MDimune shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell MDimune stock?
Shareholders can sell their MDimune stock through EquityZen's private company marketplace. EquityZen's network includes over 370K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
